PROM1 and malignant colon neoplasm: In colon cancer, Yusra et al. showed that the expression levels of TGF-β receptor genes, TGFBR1 and TGFBR3, were higher in CD133 positive (+) colon CSCs, suggesting that CD133+ colon CSCs have increased sensitivity to TGF-β [36].